Relapsed/Refractory Acute Myeloid Leukaemia
3 clinical trials · Condition
◉ Watch Relapsed/Refractory Acute Myeloid Leukaemia
| Record | Firm | Date |
|---|---|---|
| Study of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AML (NCT04501120) | Ascentage Pharma Group Inc. | 2020-09-28 |
Track Relapsed/Refractory Acute Myeloid Leukaemia automatically
Every clearance here is in the API, with alerts when new ones post.